Publications by authors named "A Dabestani"
Article Synopsis
- - Benzoyl peroxide (BPO), commonly used in acne treatments, can degrade into benzene, a harmful carcinogen, especially when stored or used at high temperatures.
- - A study detected varying levels of benzene (0.16 to 35.30 ppm) in 111 over-the-counter BPO products when kept at room temperature, while a prescription version showed none at low temperatures but significant benzene at high temperatures.
- - Experiments revealed that using BPO on skin models can lead to detectable benzene levels in the air, especially under UV light, highlighting health risks from benzene exposure regardless of the initial concentration in the products.
The quality of drug products in the United States has been a matter of growing concern. Buyers and payers of pharmaceuticals have limited insight into measures of drug-product quality. Therefore, a quality-score system driven by data collection is proposed to differentiate between the qualities of drug products produced by different manufacturers.
View Article and Find Full Text PDFThe intent of this article is to evaluate a novel approach, using rapid cycle analytics and real world evidence, to optimize and improve the medication evaluation process to help the formulary decision making process, while reducing time for clinicians. The Pharmacy and Therapeutics (P&T) Committee within each health system is responsible for evaluating medication requests for formulary addition. Members of the pharmacy staff prepare the drug monograph or a medication use evaluation (MUE) and allocate precious clinical resources to review patient charts to assess efficacy and value.
View Article and Find Full Text PDFPurpose: To describe our medical center's pharmacy services preparedness process and offer guidance to assist other institutions in preparing for surges of critically ill patients such as those experienced during the coronavirus disease 2019 (COVID-19) pandemic.
Summary: The leadership of a department of pharmacy at an urban medical center in the US epicenter of the COVID-19 pandemic proactively created a pharmacy action plan in anticipation of a surge in admissions of critically ill patients with COVID-19. It was essential to create guidance documents outlining workflow, provide comprehensive staff education, and repurpose non-intensive care unit (ICU)-trained clinical pharmacotherapy specialists to work in ICUs.